--- title: "Labour Pain Relief Options: Video Versus Pamphlet for Easing Fear of Birth and Improving Preparedness in Pregnant Patients, an RCT" nct_id: NCT07437703 overall_status: NOT_YET_RECRUITING phase: NA sponsor: Fraser Health study_type: INTERVENTIONAL primary_condition: Labour Pain canonical_url: "https://parkinsonspathways.com/agent/trials/NCT07437703.md" clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07437703" ct_last_update_post_date: 2026-02-27 last_seen_at: "2026-05-12T07:02:28.785Z" source: ClinicalTrials.gov (mirrored, no enrichment) --- # Labour Pain Relief Options: Video Versus Pamphlet for Easing Fear of Birth and Improving Preparedness in Pregnant Patients, an RCT **Official Title:** Labour Pain Relief Options: Video Versus Pamphlet for Easing Fear of Birth and Improving Preparedness in Pregnant Patients, a Randomized Controlled Trial **NCT ID:** [NCT07437703](https://clinicaltrials.gov/study/NCT07437703) ## Key Facts - **Status:** NOT_YET_RECRUITING - **Phase:** NA - **Study Type:** INTERVENTIONAL - **Target Enrollment:** 100 - **Lead Sponsor:** Fraser Health - **Conditions:** Labour Pain - **Start Date:** 2026-04-01 - **Completion Date:** 2026-12-31 - **CT.gov Last Update:** 2026-02-27 ## Brief Summary The goal of this clinical trial is to investigate whether a structured educational video improves outcomes related to fear of birth and patient preparedness for pregnant adults who are planning to labour. The primary objective is to evaluate whether an educational video can reduce fear of childbirth more effectively than a pamphlet. Patients will complete a baseline questionnaire assessing their knowledge of labour pain relief options and their current fear of childbirth. The control group will be provided an electronic version of a pamphlet while the intervention group will watch an educational video outlining pharmacologic and non-pharmacologic options for labour pain relief. Immediately after the intervention, all participants will complete the same questionnaire to assess changes in fear and knowledge. ## Detailed Description Study Design The study will employ a randomized controlled trial design. Participants will be randomly assigned to one of two parallel arms: (1) a written pamphlet or (2) an intervention (7-minute educational video). On the study day, all participants will complete a baseline questionnaire assessing their knowledge of labour pain relief options and their current fear of childbirth. Following informed consent, participants in the control group will be provided an electronic version of the pamphlet; those in the intervention group will watch the video. Immediately after the intervention, all participants will complete the same questionnaires to assess changes in fear and knowledge. Participant Selection Participants will be recruited during their routine prenatal appointments at antenatal clinics affiliated with this hospital. Every eligible patient will be invited to participate. Inclusion criteria 1. Adults aged 19 years and over 2. Primiparous patients over 32 weeks of gestation planning to labour Exclusion Criteria 1. Emergency delivery / already in labour 2. Patients who are not intending to labour (i.e. primary elective cesarean sections) 3. Unable to give consent 4. Unable to communicate in English. Recruitment Recruitment will occur at prenatal interactions using multiple methods: * Self-referral via posters and flyers * In-person recruitment * Clinic staff assistance Randomization Participants will be randomized in a 1:1 ratio to either the intervention group (educational video) or the control group (written pamphlet). Allocation concealment will be preserved by randomizing the allocation table within REDCap, which will remain hidden from study personnel during the randomization process. Group assignment will be revealed only after participants have completed the baseline assessment and have been enrolled in the study. Follow-up Questionnaires Follow-up will be conducted two weeks after their estimated due date (EDD). If the follow-up questionnaire is incomplete, one email follow-up reminder will be sent 2-weeks later (at 4-weeks post EDD). Sample Size Calculation The primary outcome of this study is the change in fear of birth, measured using a validated 2-item Visual Analog Scale (VAS), with each item scored from 0 to 100 and averaged. To detect a 10-point difference with 90% power and a two-sided alpha of 0.05, we estimate that a total of 88 participants (44 per group) are needed. To account for an anticipated attrition rate, we plan to recruit a total of 100 participants (50 per group). This sample size will ensure the study is adequately powered to assess the effectiveness of the educational video in reducing fear of birth compared to standard pamphlet-based education. Analysis Plan All data will be analyzed using Stata 13.1. P\<0.05 will be considered significant. Normally distributed continuous and count variables will be compared using paired t-tests. Ordinal/categorical variables will be analyzed with t-tests, and binary categorial variables (yes/no) will be analyzed using Fisher's exact or Chi-Square tests. ## Eligibility - **Minimum age:** 19 Years - **Sex:** FEMALE - **Healthy Volunteers:** No ``` Inclusion Criteria: * Adults age 19 years and over * Primiparous patients over 32 weeks of gestation * Planning to labour Exclusion Criteria: * Emergency delivery/already in labour * Patients who are not intending to labour * Unable to give consent * Unable to communicate in English ``` ## Arms - **Pamphlet** (ACTIVE_COMPARATOR) — A pamphlet about labour pain relief options produced by BC Women's Hospital and published on their website - **Video** (EXPERIMENTAL) — A video about labour pain relief options produced by Royal Columbian Hospital anesthesiologists ## Interventions - **Pamphlet** (BEHAVIORAL) — Electronic version of pamphlet with comprehensive and up-to-date content on both pharmacologic and non-pharmacologic pain relief options during labour. - **Video** (BEHAVIORAL) — An educational video featuring anesthesiologists explaining both pharmacologic and non-pharmacologic pain relief options ## Primary Outcomes - **Change in fear of birth (FOB)** _(time frame: From enrollment to end of post-intervention questionnaire (same day))_ — The primary outcome is the change in fear of birth (FOB), as assessed immediately after reviewing the educational material using a two-item visual analog scale. The FOB total score is derived by calculating the average of the two items that assess fear and worry regarding the upcoming birth, each ranging from 0 to 100, with higher scores indicating higher FOB. ## Secondary Outcomes - **Change in fear and worry scores** _(time frame: From enrollment to end of post-intervention questionnaire (same day))_ - **Changes in knowledge about pain relief options** _(time frame: From enrollment to end of post-intervention questionnaire (same day))_ - **Birth satisfaction** _(time frame: From enrollment to end of follow-up (2 weeks post estimated delivery date))_ - **Type of analgesia used during labour** _(time frame: From enrollment to end of follow-up (2 weeks post estimated delivery date))_ ## Recent Field Changes (last 30 days) - `status.overallStatus` — added _(2026-05-12)_ - `status.primaryCompletionDate` — added _(2026-05-12)_ - `status.completionDate` — added _(2026-05-12)_ - `status.lastUpdatePostDate` — added _(2026-05-12)_ - `design.phases` — added _(2026-05-12)_ - `design.enrollmentCount` — added _(2026-05-12)_ - `eligibility.criteria` — added _(2026-05-12)_ - `eligibility.minAge` — added _(2026-05-12)_ - `eligibility.sex` — added _(2026-05-12)_ - `outcomes.primary` — added _(2026-05-12)_ - `outcomes.secondary` — added _(2026-05-12)_ - `armsInterventions.arms` — added _(2026-05-12)_ - `armsInterventions.interventions` — added _(2026-05-12)_ - `sponsor.lead` — added _(2026-05-12)_ - `results.hasResults` — added _(2026-05-12)_ --- *Canonical: https://parkinsonspathways.com/agent/trials/NCT07437703.md* *Source data (authoritative): https://clinicaltrials.gov/study/NCT07437703* *This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*